How to Value a Family-Owned Manufacturing Business — Conclave Partners

Family manufacturers are among the hardest small and mid-sized businesses to value accurately, and the reason has little to do with the machines. It is that the reported profit of a company owned and run by one family is rarely the profit a buyer would inherit.

Over twenty or thirty years, a family adjusts the accounts to suit the family. The founder draws a salary that reflects what the company could afford rather than what the role is worth. The factory sits on land owned personally by the parents, rented to the company at a number chosen for tax reasons. A son manages procurement, a daughter handles the books, a brother-in-law appears on payroll and rarely on site. None of this is improper. All of it makes the headline EBITDA close to meaningless until it is rebuilt.

This article sets out how that rebuilding works, what multiples the market actually pays for manufacturing businesses, and which adjustments buyers accept or reject.

Family firms dominate European industry and they last. Research cited by PwC puts the average lifespan of a European family business at around 60 years against roughly 12 years for non-family companies, and Europe holds a notably high share of fourth-generation-and-beyond firms — around 24%, more than double other regions.

Longevity cuts both ways at exit. A company that has traded for decades has deep customer relationships, a trained workforce and paid-for equipment. It also has decades of accumulated informality: undocumented agreements, blurred lines between household and company, and a cost base shaped by tax planning rather than operating reality.

Succession pressure makes this urgent. The widely cited pattern is that roughly 30% of family businesses reach the second generation, about 12% the third and only around 3% the fourth. Surveys of European family firms consistently find that only about half of next-generation members are aware of any formal succession plan. When no successor emerges, a sale becomes the exit — and the accounts were never built to be examined by a stranger.

Normalisation means reconstructing what the business would earn under a new owner paying market rates for everything. This is the heart of valuing a family manufacturer, and it is where most of the value is won or lost.

The first adjustment is always management pay. If the founder draws €40,000 running a company that would require a €120,000 plant director, EBITDA is overstated by €80,000 and the buyer will deduct it. If the founder instead draws €300,000 from a business where €120,000 buys the role, EBITDA is understated by €180,000 and the seller is entitled to add it back.

The same logic applies to every relative on the payroll. The question is never who they are; it is what the company would have to pay a non-family professional to do that work, and whether the work is needed at all. Three relatives doing two jobs means one salary is an add-back. A relative doing a real job at below-market pay is a deduction, because the buyer will have to pay properly to keep the function running.

Most family manufacturers occupy premises the family owns personally. The rent charged is usually either far below market — to keep company profit low — or far above it, to move money out tax-efficiently.

Buyers restate rent to market and adjust EBITDA accordingly. This single item routinely moves valuations by a full turn, because a below-market rent inflates profit that the buyer cannot sustain once a proper lease is signed. Sellers should establish an independent market rent early and decide whether the property is part of the transaction or stays with the family under a formal lease. In our work at Conclave Partners, unresolved property arrangements are one of the most common reasons a manufacturing deal stalls late.

Family manufacturers frequently trade with entities owned by the same family: a haulage company, a tooling supplier, a sales agent abroad. Where those transactions are not at arm's length, they distort margin in one direction or the other, and buyers will restate them.

Personal costs run through the company follow the same treatment — vehicles, travel, insurance, the occasional building project. These are legitimate add-backs when they genuinely will not continue, but every one of them must be evidenced by invoice.

Add-backs are where credibility is won and lost. Buyers routinely accept documented owner-compensation adjustments, market-rent restatements, one-off legal or restructuring costs, and genuinely non-recurring plant repairs.

They routinely reject: unexplained "normalisation" of ordinary operating costs, add-backs for expenses that will plainly recur, optimistic reversals of bad debt, and anything supported only by the owner's word. A quality-of-earnings review commissioned before going to market is the practical answer. Unsupported adjustments do not merely get removed — a buyer who stops trusting the earnings figure applies a discount to the entire business rather than to the disputed line.

Manufacturing multiples vary more by business character than by sector label. Published benchmarks cluster in a familiar band: for typical lower middle market manufacturers, roughly 5x to 8x adjusted EBITDA, with 2026 commentary putting the core lower-middle-market range nearer 5x to 7x.

Deal size matters more than owners expect. Private equity buyers paid around 7.2x EBITDA on average for sponsored deals between $10 million and $500 million of enterprise value in 2025. Below that, the curve falls away: around 6.4x at roughly $20 million of enterprise value, and closer to 5.5x below $10 million.

Character matters more still. Small machine shops with heavy customer concentration transact around 3x to 5x. Diversified contract manufacturers with $3–15 million of EBITDA sit in the 5x to 8x band. Regulated, hard-to-replicate niches — medical device contract manufacturing, aerospace precision machining — reach 8x to 12x.

Two cautions apply to every published figure. These benchmarks are dominated by larger, professionally run transactions, and in the lower middle market transactions Conclave Partners observes, family businesses consistently clear below them. And a multiple applied to an unverified earnings figure is meaningless: the normalisation work described above determines the base the multiple is applied to, which is why it matters more than the multiple itself.

Beyond earnings quality, four factors do most of the work.

Customer concentration. A manufacturer where one customer represents forty per cent of revenue is asking the buyer to underwrite that relationship. Concentration is not fatal where contracts are long, documented and institutional rather than personal, but it compresses the multiple whenever the relationship lives with the retiring owner.

Machine age and deferred capital expenditure. Family manufacturers often run equipment far beyond its book life. This flatters EBITDA, because maintenance capital expenditure has been postponed rather than eliminated. Buyers normalise for the real replacement cycle, and a deferred programme becomes a direct price deduction. Owners planning an exit are usually better served by making the investment than by presenting inflated earnings that will not survive diligence.

Management depth. If pricing, key customer relationships and production scheduling all run through one person who is about to retire, the buyer is acquiring a job rather than a business. Building and documenting a management layer below the family is the single most reliable way to widen the buyer pool.

Documentation. Undocumented supply agreements, informal employment terms and missing environmental or safety compliance records are common in long-established family firms and are treated as risk, which means price.

Where a credible successor exists, an internal transfer can preserve the business and the family's position, though it rarely delivers full market value in cash and often requires the retiring generation to finance it.

Where no successor exists, the honest question is timing. Family businesses that come to market only when the founder's health or energy forces the decision usually arrive unprepared, with an unnormalised cost base, deferred capital expenditure and no management layer. The alternative — beginning preparation twelve to twenty-four months before any intention to sell — consistently produces better outcomes, and the difference tends to be measured in turns of EBITDA rather than percentage points.

A third route sits between the two: selling a majority to a financial buyer while a family member remains in management and retains a minority holding. It suits families who want liquidity without a clean break, though it means accepting a partner in decisions the family previously made alone.

The work is unglamorous and takes time.

- Restate owner and family compensation to market, and remove roles the business does not need. - Establish an independent market rent for family-owned property and formalise the lease. - Put related-party trading on arm's-length terms, documented. - Commission a quality-of-earnings review and fix what it finds before a buyer does. - Address the deferred capital expenditure programme rather than carrying it into the sale. - Reduce customer concentration where realistic, and convert personal relationships into contracts. - Build and document a management layer that operates without the family.

Advisers such as Conclave Partners generally recommend running this exercise on the business first, because problems a buyer discovers cost considerably more than problems fixed in advance.

The recurring failures are consistent.

Owners value the company on reported EBITDA without normalisation, then treat the buyer's restated figure as an insult rather than arithmetic. They present add-backs without evidence and lose credibility on the whole earnings statement. They leave the family property question unresolved until diligence. They defer machine replacement to improve short-term profit. And they conflate what the business is worth to the family with what it is worth to a buyer who must pay market rates for everything the family provided cheaply.

The last of these is the hardest and the most important. Conclave Partners sees it repeatedly: the number in the owner's head reflects thirty years of effort, while the number on the offer reflects the cash the business will generate for someone else.

Valuing a family-owned manufacturer is mostly an exercise in rebuilding the profit and loss account as it would look under new ownership. Owner pay, family rent, relatives on payroll and related-party trading all have to be restated to market, and every adjustment has to be evidenced.

Only then does the multiple matter — and the multiple that applies depends on customer concentration, equipment condition, management depth and how much of the business walks out with the retiring generation. Families that do this work deliberately, well before they need to sell, meet buyers with a defensible number. Those that do not tend to discover the gap between family value and market value at the worst possible moment.

Compare every cost the family controls against market rates: your own salary against what a hired manager would cost, family rent against an independent valuation, relatives' pay against the market rate for the work they actually do. The net of those differences is the correction to your reported figure.

Only those you can evidence. Documented owner-compensation adjustments, market-rent restatements and genuinely one-off costs are standard. Anything supported only by explanation tends to be rejected, and a pattern of unsupported adjustments damages trust in the whole earnings figure.

Both routes are common. Keeping it and granting a formal market-rate lease gives the family an income stream and reduces the purchase price. Selling it with the business simplifies the transaction and widens the buyer pool. What is not workable is leaving the arrangement undefined into diligence.

For lower middle market manufacturing, commonly cited ranges run from roughly 5x to 8x adjusted EBITDA, with small shops carrying customer concentration lower and regulated precision niches materially higher. Published benchmarks skew toward larger transactions, so treat them as direction rather than a quotation.

Not in itself. It reduces value when roles are duplicated, pay is off-market, or the business cannot function once those individuals leave. Documented roles at market pay, held by people who intend to stay, are an asset rather than a discount.

Twelve to twenty-four months to restate compensation and rent, formalise related-party arrangements, address deferred capital expenditure and build a management layer. Compressing it into the months after deciding to sell rarely works.

For a family manufacturer with significant normalisation, generally yes. It converts adjustments the owner asserts into adjustments an independent party has tested, which is the difference between a negotiation about arithmetic and a negotiation about trust.

Ildar Zakirov — Conclave Partners ildar@conclavepartners.com

Sergi Kosiakof — Conclave Partners sergi@conclavepartners.com